The role of epidermal growth factor receptor (EGFR) in the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer patients

Background. Identification of predictive molecular markers of triple-negative breast cancer (TNBC) will enable the evaluation of the efficacy of neoadjuvant chemotherapy (NACT) and define optimum approaches for the prognosis of the disease course in TNBC patients.The aim of the study was to examine...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: N. N. Babyshkina, T. A. Dronova, E. A. Zambalova, M. V. Zavyalova, E. M. Slonimskaya, N. V. Cherdyntseva
Materialtyp: Artigo
Språk:Inglês
Publicerad: Siberian State Medical University (Tomsk) 2020-04-01
Serie:Bûlleten' Sibirskoj Mediciny
Ämnen:
triple-negative breast cancer
neoadjuvant chemotherapy
epidermal growth factor receptor (egfr)
gene polymorphisms
Länkar:https://bulletin.tomsk.ru/jour/article/view/2675
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk